July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Autotaxin protects retinal ganglion cells in an autoimmune glaucoma model
Author Affiliations & Notes
  • Stephanie C Joachim
    Experimental Eye Research Institute, Ruhr University, Bochum, Germany
  • Sabrina Reinehr
    Experimental Eye Research Institute, Ruhr University, Bochum, Germany
  • Gesa Stute
    Experimental Eye Research Institute, Ruhr University, Bochum, Germany
  • Christoph Ullmer
    Roche Pharma Research & Early Development, F. Hoffmann-La Roche AG, Basel, Switzerland
  • H Burkhard Dick
    Experimental Eye Research Institute, Ruhr University, Bochum, Germany
  • Footnotes
    Commercial Relationships   Stephanie Joachim, F. Hoffmann-La Roche Ltd. (F), F. Hoffmann-La Roche Ltd. (R); Sabrina Reinehr, None; Gesa Stute, None; Christoph Ullmer, F. Hoffmann-La Roche Ltd . (E); H Burkhard Dick, None
  • Footnotes
    Support  F. Hoffmann-La Roche Ltd.
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 6144. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Stephanie C Joachim, Sabrina Reinehr, Gesa Stute, Christoph Ullmer, H Burkhard Dick; Autotaxin protects retinal ganglion cells in an autoimmune glaucoma model. Invest. Ophthalmol. Vis. Sci. 2018;59(9):6144.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The autotaxin-lysophosphatidic acid (ATX-LPA) signaling pathway plays a role in a variety of autoimmune diseases, such as rheumatoid arthritis, or neurodegeneration. A link to a role in the pathogenesis of glaucoma is suggested by an overactive ATX/LPA axis in patient’s aqueous humor samples. Hence, it was tested if ATX inhibition protects retinal ganglion cells (RGC) and optic nerve axons in an autoimmune glaucoma model using two different ATX inhibitors. In this model, RGC loss and optic nerve degeneration occur IOP independently.

Methods : Rats were immunized with bovine optic nerve homogenate antigen (ONA). Following groups were compared: control group (Co), immunization group (ONA) and the ONA plus autotaxin inhibitors, PF-8380 (60 mpk; Roche) and ATX-R (20 mpk; Roche), groups. Oral treatment was started 7 days prior to immunization. 28 days after immunization optic nerves and retinas were processed for immunohistology to evaluate neurofilament (SMI-32), RGCs (Brn-3a), macroglia (GFAP), and microglia (Iba1, ED1).

Results : Significantly fewer RGCs were observed in the ONA (47.3±3.2 cells/mm) group when compared to controls (63.2±11.4 cells/mm; p=0.039). No significant RGC loss was noted in the PF-8380 (51.7±9.7 cells/mm; p=0.21) and ATX-R group (48.3±9.6 cells/mm; p=0.06). Gliosis was seen in ONA retinas (p=0.027), but not in the treatment groups (both: p=0.99). In the ONA group, significantly more microglia (22.1±7.8 cells/mm; p=0.042) as well as active microglia (7.7±6.3 cells/mm; p=0.021) were observed in comparison to controls (Iba1: 13.7±3.0 cells/mm; ED1: 1.5±1.3 cells/mm). Whereas no changes were noted in the PF-8380 (Iba1: 18.0±4.8 cells/mm; ED1: 2.5±1.7 cells/mm) and ATX-R (Iba1: 19.8±2.8 cells/mm; ED1: 5.1±1.9 cells/mm) treatment group. A significantly increased SMI-32 score was seen in the ONA group (p=0.025), indicating degenerated neurofilaments, but not in the treatment groups (p>0.7). Additionally, treatment with PF-8380 and ATX-R decreased the number of microglia in the optic nerve.

Conclusions : The two different ATX inhibitors protected RGCs and optic nerve axons in the autoimmune glaucoma model. Results from this study indicate that ATX inhibitors might serve as novel therapeutic targets for glaucoma.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×